Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, IgG | 4 | 2025 | 63 | 0.670 |
Why?
|
| Plasmodium falciparum | 2 | 2025 | 97 | 0.390 |
Why?
|
| HIV Antibodies | 2 | 2024 | 71 | 0.380 |
Why?
|
| Antibodies, Neutralizing | 3 | 2024 | 497 | 0.330 |
Why?
|
| HIV-1 | 2 | 2024 | 487 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 3 | 2025 | 1049 | 0.300 |
Why?
|
| Macaca mulatta | 3 | 2024 | 513 | 0.280 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2024 | 76 | 0.260 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2024 | 100 | 0.250 |
Why?
|
| Protozoan Proteins | 2 | 2025 | 135 | 0.250 |
Why?
|
| Killer Cells, Natural | 2 | 2024 | 357 | 0.230 |
Why?
|
| Malaria, Falciparum | 2 | 2025 | 72 | 0.220 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2024 | 26 | 0.220 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2025 | 87 | 0.220 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 80 | 0.210 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 198 | 0.200 |
Why?
|
| Monocytes | 1 | 2024 | 346 | 0.190 |
Why?
|
| Homeostasis | 1 | 2024 | 748 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2025 | 635 | 0.150 |
Why?
|
| HIV Infections | 2 | 2024 | 2030 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4823 | 0.080 |
Why?
|
| Animals | 6 | 2025 | 36189 | 0.070 |
Why?
|
| Plasmodium berghei | 1 | 2025 | 14 | 0.060 |
Why?
|
| Smoke | 1 | 2025 | 66 | 0.060 |
Why?
|
| Antibody Affinity | 1 | 2024 | 41 | 0.060 |
Why?
|
| Immunomodulation | 1 | 2024 | 80 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2025 | 131 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 130 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2024 | 194 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 439 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2024 | 395 | 0.050 |
Why?
|
| Mice | 3 | 2025 | 18930 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2024 | 477 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 1013 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 453 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2021 | 40 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 30 | 0.040 |
Why?
|
| Protein Binding | 1 | 2025 | 1850 | 0.040 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 19 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2021 | 95 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 329 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 699 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 868 | 0.040 |
Why?
|
| Humans | 7 | 2025 | 133147 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 415 | 0.040 |
Why?
|
| Dependovirus | 1 | 2021 | 153 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2521 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 356 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 1377 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1084 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3794 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2125 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3131 | 0.030 |
Why?
|
| Female | 3 | 2025 | 71382 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4755 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13235 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 14862 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 20528 | 0.020 |
Why?
|
| Child | 1 | 2024 | 25828 | 0.010 |
Why?
|
| Male | 1 | 2024 | 65472 | 0.010 |
Why?
|